via Infection Control Today
RMIT scientists in Melbourne have led an international collaboration that potentially unlocks better treatment of viral diseases, including the flu and common cold.
The results were published in the prestigious scientific and medical journal Nature Communications.
Each year the flu virus sends 13,500 Australians to hospital and causes more than 3000 deaths among those aged over 50. The global burden is also staggering, with more than 5 million cases of infection annually with up to 10 per cent resulting in death.
The RMIT senior authors, Dr Stavros Selemidis (ARC Future Fellow) and Dr Eunice To (first author), collaborated with Professor Doug Brooks from University South Australia, Professor John O’Leary from Trinity College Dublin, Monash University’s Professor Christopher Porter, and other scientists and clinicians to investigate how viruses cause disease in humans.
The researchers discovered that a 1.5 billion-year-old cell biological process found in plants, fungi and mammals enhances viral disease in mice and highly likely also in humans. They identified a protein, Nox2 oxidase, that is activated by viruses, including influenza, rhinovirus (the common cold), dengue and HIV.
Once activated, Nox2 oxidase suppresses the body’s key antiviral reaction and its ability to fight and clear the viral infection, which in turn results in a stronger or more virulent disease in mice.
The study also investigated a new prototype drug to treat these debilitating viral diseases.
The researchers found that the Nox2 oxidase protein activated by the viruses is located in a cell compartment called endosomes. They carefully modified a chemical that inhibits or restrains the activity of Nox2 oxidase.
Their customised drug was found to be very effective at suppressing disease caused by influenza infection.
Selemidis, head of the Oxidant and Inflammation Biology Group within the Chronic Infectious and Inflammatory Diseases program at RMIT, said: “Current treatment strategies are limited as they specifically target circulating viruses and have either unknown or very little effect against new viruses that enter the human population.
“We have identified a protein of the immune system that contributes to the disease caused by flu viruses irrespective of their strain.
“We also developed a novel drug delivery system to target this protein, which drastically alleviated the burden of viral disease.
“The strength of this work is the multidisciplinary approach taken and the degree of collaboration. It includes researchers and clinicians from eight universities across Australia, the United States and Ireland.
“This work attracted considerable interest at the NADPH Oxidase GORDON conference in the USA last year.”
To said: “This work identifies a treatment strategy that has the potential to alleviate the symptoms caused by some of the most devastating viruses worldwide, including the flu.”
Learn more: New research points to treatment breakthrough for viruses
The Latest on: Viral diseases
- West Nile Virus infected mosquitoes found in Mahoning Countyon August 3, 2022 at 7:14 am
Mahoning County Public Health officials are reporting the discovery of mosquitoes infected with the West Nile Virus in the county. A news release from the health department says the mosquitoes were ...
- Men Who Died From Monkeypox Brain Swelling Were Healthy Before Virus Hiton August 3, 2022 at 4:48 am
A report said the two men who died in Spain were not immunocompromised and had no chronic illnesses that could have been risk factors.
- Monkeypox: Union Health Ministry lists Do's and Don’ts to prevent viral diseaseon August 3, 2022 at 3:34 am
India currently has eight confirmed cases of monkeypox, out of which five patients have a history of overseas travel, Union Health Minister Mansukh Mandaviya told Parliament on Tuesday ...
- Polio virus found in New York wastewater, but no new caseson August 3, 2022 at 3:10 am
The polio virus was detected in wastewater samples from the suburban county near New York City where an unvaccinated adult recently contracted the life-threatening disease, but health officials said ...
- Monkeypox: Health ministry lists dos and don'ts on viral disease. Read hereon August 2, 2022 at 9:34 pm
Till now, India has reported eight confirmed cases of monkeypox, with Kerala and Delhi accounting for five and three patients respectively.
- How does monkeypox spread? An infectious disease expert explainson August 1, 2022 at 7:59 pm
When it comes to spreading monkeypox, one doctor broke it down into three levels of risk. Here’s what to know.
- One-two punch from pair of common viruses may trigger Alzheimer’s diseaseon July 31, 2022 at 8:10 pm
A fascinating new collaborative study, between researchers at the University of Oxford and Tufts University, has found two common viruses may be working in tandem to trigger the earliest stages of ...
- Common Viruses May Be Triggering Alzheimer’s Diseaseon July 31, 2022 at 2:28 am
Shingles infection may awaken dormant neurological herpes viruses, causing inflammation and accumulation of Alzheimer’s associated proteins in the brain. Alzheimer’s disease is the most common cause ...
- Common viruses may be triggering the onset of Alzheimer’s diseaseon July 29, 2022 at 2:28 pm
Two common viruses lie dormant in neurons – herpes simplex virus (HSV), and varicella zoster virus (VZV). Lab models of the human brain show that activation or re-infection of VZV can trigger ...
- Chickenpox Virus May Trigger the Onset of Alzheimer’s Diseaseon July 29, 2022 at 2:21 pm
Varicella zoster virus (VZV), the virus that causes chickenpox and shingles, may activate the herpes simplex virus and trigger the onset of Alzheimer's disease, a new mouse study found.
via Google News and Bing News
